Your browser doesn't support javascript.
loading
Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Spillane, Susan; Baxi, Shrujal; Torres, Aracelis Z; Lenis, David; Freedman, Andrew N; Mariotto, Angela B; Sharon, Elad.
  • Spillane S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Baxi S; Flatiron Health Inc, New York, New York, USA.
  • Torres AZ; Flatiron Health Inc, New York, New York, USA.
  • Lenis D; Covera Health, New York, New York, USA.
  • Freedman AN; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
  • Mariotto AB; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
  • Sharon E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.
Oncologist ; 25(11): e1753-e1762, 2020 11.
Article en En | MEDLINE | ID: mdl-33094874

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article